» Articles » PMID: 35055304

Single Nano-Sized Metal-Organic Framework for Bio-Nanoarchitectonics with In Vivo Fluorescence Imaging and Chemo-Photodynamic Therapy

Overview
Date 2022 Jan 21
PMID 35055304
Authors
Affiliations
Soon will be listed here.
Abstract

Theranostics is an emerging technique for cancer treatments due to its safety and high efficiency. However, the stability, efficiency, and convenience of preparation are the main challenges for developing theranostics. Here we describe a one-pot process for biocompatible metal-organic framework (MOF)-based theranostics. The ligand HL designed for the MOF enables both red fluorescence emission and photodynamic therapy (PDT). The frame and regular channel structure of HL-MOF empower the theranostics with good drug delivery performance, and the uniform and nano-sized particles facilitate the in vivo imaging/therapy applications. In vivo fluorescence imaging and in vitro chemo-photodynamic therapy were achieved with the MOF without any further modification. Our results reveal an effective strategy to achieve multifunctional theranostics by the synergistic action of the organic ligand, metal node, and channel structure of MOF nanoparticles.

Citing Articles

Porphyrin-engineered nanoscale metal-organic frameworks: enhancing photodynamic therapy and ferroptosis in oncology.

Zou Y, Chen J, Luo X, Qu Y, Zhou M, Xia R Front Pharmacol. 2024; 15:1481168.

PMID: 39512824 PMC: 11541831. DOI: 10.3389/fphar.2024.1481168.


Recent progress and challenges of MOF-based nanocomposites in bioimaging, biosensing and biocarriers for drug delivery.

Nguyen N, Nguyen T, Ge S, Liew R, Nguyen D, Tran T Nanoscale Adv. 2024; 6(7):1800-1821.

PMID: 38545292 PMC: 10964756. DOI: 10.1039/d3na01075a.


2D Materials Nanoarchitectonics for 3D Structures/Functions.

Ariga K Materials (Basel). 2024; 17(4).

PMID: 38399187 PMC: 10890396. DOI: 10.3390/ma17040936.


Materials Nanoarchitectonics at Dynamic Interfaces: Structure Formation and Functional Manipulation.

Ariga K Materials (Basel). 2024; 17(1).

PMID: 38204123 PMC: 10780059. DOI: 10.3390/ma17010271.


Construction of PCN-222 and Atomically Thin 2D CNs Van Der Waals Heterojunction for Enhanced Visible Light Photocatalytic Hydrogen Production.

Wu L, Mi X, Wang S, Huang C, Zhang Y, Wang Y Nanomaterials (Basel). 2023; 13(8).

PMID: 37110903 PMC: 10143698. DOI: 10.3390/nano13081318.


References
1.
Chen R, Zhang J, Chelora J, Xiong Y, Kershaw S, Li K . Ruthenium(II) Complex Incorporated UiO-67 Metal-Organic Framework Nanoparticles for Enhanced Two-Photon Fluorescence Imaging and Photodynamic Cancer Therapy. ACS Appl Mater Interfaces. 2017; 9(7):5699-5708. DOI: 10.1021/acsami.6b12469. View

2.
He C, Lu K, Liu D, Lin W . Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J Am Chem Soc. 2014; 136(14):5181-4. PMC: 4210117. DOI: 10.1021/ja4098862. View

3.
Lu K, Aung T, Guo N, Weichselbaum R, Lin W . Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications. Adv Mater. 2018; 30(37):e1707634. PMC: 6586248. DOI: 10.1002/adma.201707634. View

4.
Lawson H, Walton S, Chan C . Metal-Organic Frameworks for Drug Delivery: A Design Perspective. ACS Appl Mater Interfaces. 2021; 13(6):7004-7020. PMC: 11790311. DOI: 10.1021/acsami.1c01089. View

5.
Jiang Z, Xu X, Ma Y, Cho H, Ding D, Wang C . Filling metal-organic framework mesopores with TiO for CO photoreduction. Nature. 2020; 586(7830):549-554. DOI: 10.1038/s41586-020-2738-2. View